Never miss out on the latest news!
Sign up to the Thrombosis Adviser newsletter.
Professor Paolo Prandoni looks at the role of ASA in extended VTE treatment and discusses the recent EINSTEIN CHOICE study, which compared two doses of rivaroxaban to ASA for extended VTE treatment
© Bayer AG, 2020 | Approval number PP-XAR-ALL-1747-1